For research use only. Not for therapeutic Use.
STF-62247 (CAT: I003123) is a small-molecule inhibitor that targets C-X-C chemokine receptor type 4 (CXCR4), a receptor involved in various biological processes, including tumor growth, metastasis, and immune cell trafficking. It has shown promise in preclinical studies for its potential use in treating cancer and autoimmune diseases by blocking CXCR4-mediated signaling. STF-62247 may also enhance the effectiveness of existing cancer therapies and reduce tumor progression. Ongoing research is focused on evaluating its safety and efficacy in clinical settings.
| Catalog Number | I003123 |
| CAS Number | 315702-99-9 |
| Synonyms | N-(3-methylphenyl)-4-pyridin-4-yl-1,3-thiazol-2-amine |
| Molecular Formula | C15H13N3S |
| Purity | ≥95% |
| Target | Autophagy |
| Solubility | DMSO: ≥ 31 mg/mL |
| Storage | store at-20℃ |
| IUPAC Name | N-(3-methylphenyl)-4-pyridin-4-yl-1,3-thiazol-2-amine |
| InChI | 1S/C15H13N3S/c1-11-3-2-4-13(9-11)17-15-18-14(10-19-15)12-5-7-16-8-6-12/h2-10H,1H3,(H,17,18) |
| InChIKey | KATNUHQNJGNLPW-UHFFFAOYSA-N |
| SMILES | CC1=CC(=CC=C1)NC2=NC(=CS2)C3=CC=NC=C3 |
